United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 24, 2026 · Filed Jul 27, 2026

On Jul 24, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$531.74 for US$5.05M under a trading plan, leaving 324,443 shares. Filed Jul 27, 2026 (Form 4).

Sold
9,500 shares
Price
US$531.74 average (US$528.72 to US$535.03)
Value
US$5.05M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 24, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 24, 2026Common StockSale820US$528.72333,123Indirect
Jul 24, 2026Common StockSale2,285US$530.45330,838Indirect
Jul 24, 2026Common StockSale1,115US$531.10329,723Indirect
Jul 24, 2026Common StockSale2,719US$532.27327,004Indirect
Jul 24, 2026Common StockSale1,818US$533.20325,186Indirect
Jul 24, 2026Common StockSale630US$534.39324,556Indirect
Jul 24, 2026Common StockSale113US$535.03324,443Indirect

Source

View original at SEC

Related